Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene.

Lerman C, Caporaso N, Main D, Audrain J, Boyd NR, Bowman ED, Shields PG.

Health Psychol. 1998 Jan;17(1):56-62.

PMID:
9459071
[PubMed - indexed for MEDLINE]
2.

Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians.

Shields PG, Lerman C, Audrain J, Bowman ED, Main D, Boyd NR, Caporaso NE.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):453-8.

PMID:
9641486
[PubMed - indexed for MEDLINE]
Free Article
3.

[Association between nicotine dependence and the -521 promoter polymorfism of the dopamine D4 receptor in patients with major depression].

Kótyuk E, Kovács-Nagy R, Faludi G, Urbán R, Rónai Z, Sasvári-Székely M, Székely A.

Neuropsychopharmacol Hung. 2009 Jun;11(2):59-67. Hungarian.

PMID:
19827313
[PubMed - indexed for MEDLINE]
Free Article
4.

Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence.

Laucht M, Becker K, Frank J, Schmidt MH, Esser G, Treutlein J, Skowronek MH, Schumann G.

J Am Acad Child Adolesc Psychiatry. 2008 Jun;47(6):673-81. doi: 10.1097/CHI.0b013e31816bff77.

PMID:
18434921
[PubMed - indexed for MEDLINE]
5.

Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors.

Vandenbergh DJ, O'Connor RJ, Grant MD, Jefferson AL, Vogler GP, Strasser AA, Kozlowski LT.

Addict Biol. 2007 Mar;12(1):106-16.

PMID:
17407504
[PubMed - indexed for MEDLINE]
6.

Using DNA in health psychology.

Plomin R.

Health Psychol. 1998 Jan;17(1):53-5. No abstract available.

PMID:
9459070
[PubMed - indexed for MEDLINE]
7.

Interaction between the dopamine D4 receptor and the serotonin transporter promoter polymorphisms in alcohol and tobacco use among 15-year-olds.

Skowronek MH, Laucht M, Hohm E, Becker K, Schmidt MH.

Neurogenetics. 2006 Nov;7(4):239-46. Epub 2006 Jul 4.

PMID:
16819620
[PubMed - indexed for MEDLINE]
8.

Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?

David SP, Niaura R, Papandonatos GD, Shadel WG, Burkholder GJ, Britt DM, Day A, Stumpff J, Hutchison K, Murphy M, Johnstone E, Griffiths SE, Walton RT.

Nicotine Tob Res. 2003 Dec;5(6):935-42.

PMID:
14668077
[PubMed - indexed for MEDLINE]
9.

The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.

Cinciripini P, Wetter D, Tomlinson G, Tsoh J, De Moor C, Cinciripini L, Minna J.

Nicotine Tob Res. 2004 Apr;6(2):229-39.

PMID:
15203796
[PubMed - indexed for MEDLINE]
10.

Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients.

Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM, Amos CI, Wan Y, Cinciripini P, Hong WK, Wu X.

J Natl Cancer Inst. 1998 Mar 4;90(5):358-63.

PMID:
9498485
[PubMed - indexed for MEDLINE]
Free Article
11.

Polymorphisms of the D4 dopamine receptor alleles in chronic alcoholism.

George SR, Cheng R, Nguyen T, Israel Y, O'Dowd BF.

Biochem Biophys Res Commun. 1993 Oct 15;196(1):107-14.

PMID:
8216280
[PubMed - indexed for MEDLINE]
12.

Association between DRD2/ANKK1 Taq1A genotypes, depression and smoking cessation with nicotine replacement therapy.

Stapleton JA, Sutherland G, O'Gara C, Spirling LI, Ball D.

Pharmacogenet Genomics. 2011 Aug;21(8):447-53. doi: 10.1097/FPC.0b013e328347473a.

PMID:
21540761
[PubMed - indexed for MEDLINE]
13.

The DRD4 VNTR polymorphism influences reactivity to smoking cues.

Hutchison KE, LaChance H, Niaura R, Bryan A, Smolen A.

J Abnorm Psychol. 2002 Feb;111(1):134-43.

PMID:
11866166
[PubMed - indexed for MEDLINE]
14.

Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderators.

Evans DE, Park JY, Maxfield N, Drobes DJ.

Genes Brain Behav. 2009 Feb;8(1):86-96. doi: 10.1111/j.1601-183X.2008.00445.x.

PMID:
19220487
[PubMed - indexed for MEDLINE]
15.

The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms.

Robinson JD, Lam CY, Minnix JA, Wetter DW, Tomlinson GE, Minna JD, Chen TT, Cinciripini PM.

Pharmacogenomics J. 2007 Aug;7(4):266-74. Epub 2006 Dec 26.

PMID:
17189962
[PubMed - indexed for MEDLINE]
16.

Evidence suggesting the role of specific genetic factors in cigarette smoking.

Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG.

Health Psychol. 1999 Jan;18(1):14-20.

PMID:
9925041
[PubMed - indexed for MEDLINE]
17.

Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch.

Johnstone EC, Yudkin PL, Hey K, Roberts SJ, Welch SJ, Murphy MF, Griffiths SE, Walton RT.

Pharmacogenetics. 2004 Feb;14(2):83-90.

PMID:
15077009
[PubMed - indexed for MEDLINE]
18.

Smoking status moderates the association of the dopamine D4 receptor (DRD4) gene VNTR polymorphism with selective processing of smoking-related cues.

Munafò MR, Johnstone EC.

Addict Biol. 2008 Sep;13(3-4):435-9. doi: 10.1111/j.1369-1600.2008.00098.x. Epub 2008 Mar 7.

PMID:
18331372
[PubMed - indexed for MEDLINE]
19.

Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.

David SP, Munafò MR, Murphy MF, Proctor M, Walton RT, Johnstone EC.

Pharmacogenomics J. 2008 Apr;8(2):122-8. Epub 2007 Mar 27.

PMID:
17387332
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Novelty seeking: interaction between parental alcohol use and dopamine D4 receptor gene exon III polymorphism over 17 years.

Lahti J, Räikkönen K, Ekelund J, Peltonen L, Raitakari OT, Keltikangas-Järvinen L.

Psychiatr Genet. 2005 Jun;15(2):133-9.

PMID:
15900228
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk